{"id":"ff","safety":{"commonSideEffects":[{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Palpitations"},{"rate":null,"effect":"Oral candidiasis"},{"rate":null,"effect":"Muscle cramps"}]},"_chembl":null,"_dailymed":{"setId":"4493c534-187e-f680-e063-6294a90aacdb","title":"FF SILICONE SPRY SANI PPK LIQUID [ZHEJIANG JINGHUI COSMETICS SHARE CO.,LTD]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The fluticasone propionate component suppresses inflammatory responses in the airways by binding glucocorticoid receptors, while the formoterol component activates beta-2 adrenergic receptors to produce sustained bronchodilation. Together, they reduce both inflammation and airway obstruction in chronic obstructive pulmonary disease and asthma.","oneSentence":"FF is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and improves bronchodilation in respiratory disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:46:42.998Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic obstructive pulmonary disease (COPD) maintenance treatment"},{"name":"Asthma maintenance treatment"}]},"trialDetails":[{"nctId":"NCT06372496","phase":"PHASE4","title":"Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-04-16","conditions":"Asthma","enrollment":1366},{"nctId":"NCT07489911","phase":"","title":"Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH)","status":"RECRUITING","sponsor":"Chiesi Slovenija, d.o.o.","startDate":"2024-11-04","conditions":"Asthma, Asthma Patients, Asthma Bronchiale","enrollment":200},{"nctId":"NCT04233866","phase":"PHASE2","title":"Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2020-08-26","conditions":"Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8","enrollment":176},{"nctId":"NCT06786767","phase":"","title":"Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting","status":"COMPLETED","sponsor":"Chiesi Bulgaria","startDate":"2025-02-01","conditions":"Asthma, Asthma Patients, Asthma Bronchiale","enrollment":281},{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT04559139","phase":"PHASE2, PHASE3","title":"Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-02-24","conditions":"Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8","enrollment":186},{"nctId":"NCT06838598","phase":"","title":"Structural and Microbiological Characterization of Arterial Catheter Biofilm in ICU's Patients Using Optical Coherence Tomography","status":"RECRUITING","sponsor":"Centre Hospitalier William Morey - Chalon sur Saône","startDate":"2024-06-03","conditions":"Biofilms, Arterial Catheterization, Peripheral, Bacteremia","enrollment":60},{"nctId":"NCT06517693","phase":"PHASE1","title":"Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-01-05","conditions":"HIV-1","enrollment":48},{"nctId":"NCT01970722","phase":"PHASE1","title":"Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2014-05-19","conditions":"FIGO Stage IVA Ovarian Cancer, FIGO Stage IVB Ovarian Cancer, Platinum-Resistant Ovarian Carcinoma","enrollment":40},{"nctId":"NCT06935344","phase":"","title":"Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study","status":"RECRUITING","sponsor":"Catholic University of the Sacred Heart","startDate":"2025-06-01","conditions":"Ovarian Cancer","enrollment":1300},{"nctId":"NCT03963167","phase":"","title":"Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)","status":"COMPLETED","sponsor":"Chiesi Italia","startDate":"2019-08-21","conditions":"COPD","enrollment":661},{"nctId":"NCT05168995","phase":"","title":"Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control","status":"COMPLETED","sponsor":"Chiesi Italia","startDate":"2022-04-12","conditions":"Asthma","enrollment":620},{"nctId":"NCT07282886","phase":"PHASE2","title":"VENTURI (VENTilation Using Respiratory Imaging)","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-03-15","conditions":"Asthma","enrollment":20},{"nctId":"NCT07406048","phase":"","title":"Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients","status":"NOT_YET_RECRUITING","sponsor":"Chiesi Farmaceutica Ltda.","startDate":"2026-01-30","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":396},{"nctId":"NCT07400497","phase":"NA","title":"Family Foundations for Special Education Trial","status":"RECRUITING","sponsor":"Penn State University","startDate":"2025-01-12","conditions":"Mental Health","enrollment":120},{"nctId":"NCT06337552","phase":"NA","title":"High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2024-04-04","conditions":"Rectal Cancer, Non-Small Cell Lung Cancer","enrollment":54},{"nctId":"NCT06015659","phase":"PHASE2","title":"ZN-c3 + Gemcitabine in Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brandon Huffman, MD","startDate":"2023-11-16","conditions":"Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma","enrollment":12},{"nctId":"NCT05449834","phase":"PHASE3","title":"Fibrinogen Early In Severe Trauma StudY II","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2022-11-21","conditions":"Trauma, Haemorrhagic Shock, Coagulopathy","enrollment":900},{"nctId":"NCT04320342","phase":"PHASE3","title":"A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2022-04-28","conditions":"COPD, COPD Exacerbation","enrollment":3433},{"nctId":"NCT06821061","phase":"PHASE1, PHASE2","title":"A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2025-02-10","conditions":"Influenza, COVID-19 (Coronavirus Disease 2019)","enrollment":2650},{"nctId":"NCT07301736","phase":"PHASE2","title":"Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma","status":"RECRUITING","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2025-12-17","conditions":"Asthma","enrollment":780},{"nctId":"NCT03587662","phase":"PHASE2","title":"Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-08-17","conditions":"Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative","enrollment":30},{"nctId":"NCT05379023","phase":"NA","title":"VIdeo Telehealth in ALzheimer's: NeuroPsychology (VITAL-NP)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-06-27","conditions":"Suspected Typical Alzheimer's Disease (AD), Suspected Atypical Alzheimer's Disease (AD)","enrollment":116},{"nctId":"NCT06770972","phase":"NA","title":"Family Foundations for Individuals Pregnant Via ART","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2025-06-11","conditions":"Assisted Reproductive Technology","enrollment":40},{"nctId":"NCT07283510","phase":"NA","title":"Community-based Functional Fitness for Adults Aging With Mobility Disability","status":"COMPLETED","sponsor":"University of Kansas","startDate":"2023-10-17","conditions":"Mobility Disability, Older Adults","enrollment":13},{"nctId":"NCT07293936","phase":"NA","title":"Post-Filter Hematocrit","status":"RECRUITING","sponsor":"Gwyndolyn M. Radford","startDate":"2025-03-15","conditions":"Continuous Renal Replacement Therapy, Renal Failure, Hemofilter Clotting","enrollment":20},{"nctId":"NCT06480890","phase":"","title":"Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients (TRIPHY)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2024-07-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":362},{"nctId":"NCT05535972","phase":"PHASE4","title":"To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-10-14","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":463},{"nctId":"NCT02364713","phase":"PHASE2","title":"MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2015-03-13","conditions":"Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma","enrollment":17},{"nctId":"NCT06264674","phase":"PHASE3","title":"Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-11-27","conditions":"Asthma","enrollment":836},{"nctId":"NCT02420847","phase":"PHASE1, PHASE2","title":"Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-07-03","conditions":"Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma","enrollment":57},{"nctId":"NCT05757102","phase":"PHASE3","title":"A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2023-04-25","conditions":"Asthma","enrollment":292},{"nctId":"NCT07192016","phase":"PHASE4","title":"129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2026-03","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":60},{"nctId":"NCT07183904","phase":"NA","title":"Nerve and Hematoma Blocks for Pain Relief During Distal Radius Fracture Reduction","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2024-01-01","conditions":"Acute Distal Radius Fracture, Displaced Distal Radius Fracture","enrollment":180},{"nctId":"NCT05743608","phase":"","title":"NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients","status":"COMPLETED","sponsor":"Chiesi Hungary Ltd.","startDate":"2023-03-29","conditions":"COPD","enrollment":1336},{"nctId":"NCT06908421","phase":"","title":"Efficacy of a Smart add-on Device in Combination With a Triple Treatment in Asthma Patients on Inhaler Technique and Adherence","status":"RECRUITING","sponsor":"Chiesi Pharma AB, Nordic","startDate":"2025-09-15","conditions":"Asthma","enrollment":60},{"nctId":"NCT05292586","phase":"PHASE3","title":"A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2022-08-31","conditions":"Asthma","enrollment":1377},{"nctId":"NCT07141836","phase":"NA","title":"Effectiveness of Elastic Chains Versus Elastics in Maxillary Canine Retraction","status":"COMPLETED","sponsor":"Sana'a University","startDate":"2024-01-30","conditions":"Elastic Chains, Elastics","enrollment":33},{"nctId":"NCT04651777","phase":"PHASE3","title":"Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Grace Parraga","startDate":"2022-08-08","conditions":"Asthma","enrollment":31},{"nctId":"NCT07139613","phase":"NA","title":"We Will Assess Zirconia Crown Restoring Endodontically Treated Posterior Teeth With Two Finish Line Designs and Two Occlusal Reduction Schemes","status":"NOT_YET_RECRUITING","sponsor":"Armed Forces Institute of Dentistry, Pakistan","startDate":"2025-08","conditions":"Zirconia Crowns","enrollment":66},{"nctId":"NCT05619575","phase":"NA","title":"Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients","status":"COMPLETED","sponsor":"Cochlear","startDate":"2022-12-20","conditions":"Hearing Impairment","enrollment":20},{"nctId":"NCT07126379","phase":"NA","title":"The Family Foundations Trial","status":"NOT_YET_RECRUITING","sponsor":"Deakin University","startDate":"2025-10-01","conditions":"Mental Health Outcomes","enrollment":472},{"nctId":"NCT04937387","phase":"PHASE3","title":"Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-07-29","conditions":"Asthma","enrollment":359},{"nctId":"NCT04880083","phase":"NA","title":"Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2021-07-09","conditions":"Digestion, Gut Microbiota","enrollment":120},{"nctId":"NCT06100042","phase":"","title":"Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chiesi Italia","startDate":"2024-04-24","conditions":"Asthma","enrollment":200},{"nctId":"NCT03248128","phase":"PHASE3","title":"Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-10-20","conditions":"Asthma","enrollment":906},{"nctId":"NCT06656780","phase":"NA","title":"Stress Inoculation Training (SIT): An Evidence-Based, Military Aligned Psychological Performance and Health Sustainment Prototype","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-08-31","conditions":"Stress, Psychological","enrollment":120},{"nctId":"NCT03432741","phase":"PHASE1","title":"Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2018-03-27","conditions":"Breast Adenocarcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma","enrollment":17},{"nctId":"NCT03187561","phase":"NA","title":"Coparenting, Infant Sleep, and Infant Development","status":"COMPLETED","sponsor":"Penn State University","startDate":"2018-11-15","conditions":"Sleep, Parenting, Marital Relationship","enrollment":216},{"nctId":"NCT05652439","phase":"","title":"PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)","status":"RECRUITING","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2022-12-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":25000},{"nctId":"NCT06948812","phase":"","title":"Foot Positions Affect Basketball Players With Flatfoot","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2023-09-01","conditions":"Balance, Proprioception, Jumping Performance","enrollment":84},{"nctId":"NCT06483555","phase":"PHASE1, PHASE2","title":"Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2025-02-06","conditions":"Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Basal Cell Neoplasm","enrollment":104},{"nctId":"NCT06907108","phase":"NA","title":"Evaluation of Clinical, Metabolic, and Physical-functional Effects of Systemic Vibratory Therapy in Metabolic Syndrome","status":"COMPLETED","sponsor":"Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas","startDate":"2020-11-01","conditions":"Metabolic Syndrome, Metabolic Syndrome Obesity, Metabolic Syndrome X","enrollment":56},{"nctId":"NCT05442463","phase":"","title":"Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2020-11-30","conditions":"Hormone Therapy","enrollment":200},{"nctId":"NCT05080283","phase":"NA","title":"Acceptance and Performance of CP1110 Sound Processor With Experienced Adult Cochlear Implant Recipients.","status":"COMPLETED","sponsor":"Cochlear","startDate":"2021-11-02","conditions":"Adult Cochlear Implant Recipients","enrollment":20},{"nctId":"NCT04923347","phase":"PHASE4","title":"A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2023-06-06","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":229},{"nctId":"NCT02506959","phase":"PHASE2","title":"Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-09-14","conditions":"Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma","enrollment":83},{"nctId":"NCT06216080","phase":"","title":"Dynamic Full-Field Optical Coherence Tomography for Structural and Microbiological Characterization of Central Venous Catheter-deposited Biofilm in Critically Ill Patients","status":"COMPLETED","sponsor":"Centre Hospitalier William Morey - Chalon sur Saône","startDate":"2023-05-01","conditions":"Healthcare Associated Infection, Critically Ill, Central Venous Catheter Associated Bloodstream Infection","enrollment":50},{"nctId":"NCT05986773","phase":"PHASE4","title":"Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance","status":"TERMINATED","sponsor":"Stadtspital Zürich","startDate":"2023-10-10","conditions":"Acute Heart Failure, Diuretic Resistance","enrollment":13},{"nctId":"NCT05286385","phase":"NA","title":"CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology","status":"COMPLETED","sponsor":"Cochlear","startDate":"2022-05-30","conditions":"Hearing Impairment, Sensorineural","enrollment":10},{"nctId":"NCT02671890","phase":"PHASE1","title":"Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2016-02-25","conditions":"Metastatic Pancreatic Adenocarcinoma, Refractory Malignant Solid Neoplasm, Stage IV Pancreatic Cancer AJCC v8","enrollment":16},{"nctId":"NCT04871529","phase":"PHASE2","title":"Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)","status":"TERMINATED","sponsor":"SWOG Cancer Research Network","startDate":"2022-08-10","conditions":"Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8","enrollment":6},{"nctId":"NCT06738199","phase":"NA","title":"Glycoprotein Matrix-Bound Iron Improves Iron Absorption","status":"COMPLETED","sponsor":"University of Mary Hardin-Baylor","startDate":"2024-02-01","conditions":"Evaluation of Bioavailability of Supplemental Forms of Iron","enrollment":17},{"nctId":"NCT06725316","phase":"NA","title":"The Effect Of 4-7-8 Breathıng Exercıs After Laparoscopıc Surgery","status":"NOT_YET_RECRUITING","sponsor":"Gazi University","startDate":"2024-11-30","conditions":"Pain","enrollment":62},{"nctId":"NCT03888131","phase":"PHASE3","title":"Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2018-07-30","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":750},{"nctId":"NCT06678191","phase":"","title":"Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting","status":"RECRUITING","sponsor":"Chiesi Hungary Ltd.","startDate":"2024-10-24","conditions":"Asthma, Chronic Obstructive Pulmonary Disease (COPD), Asthma Bronchiale","enrollment":800},{"nctId":"NCT05898984","phase":"PHASE1","title":"Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-04-24","conditions":"Asthma","enrollment":69},{"nctId":"NCT06606392","phase":"NA","title":"Effect of Biodex Balance Training and Short Foot Exercise on Myoelectric Activity of Paraspinal Muscles in Subjects with Flexible Flatfoot","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-10-28","conditions":"Flat Foot","enrollment":60},{"nctId":"NCT06595472","phase":"NA","title":"Plant Sterol-Enriched Palm Oil to Improve Lipid Profile and Inflammation in Hyperlipidemic Individuals","status":"COMPLETED","sponsor":"Institut Pertanian Bogor","startDate":"2012-06-01","conditions":"Hyperlipidemias","enrollment":102},{"nctId":"NCT05830071","phase":"PHASE1","title":"A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-03-29","conditions":"Asthma, Chronic Obstructive Pulmonary Disease (COPD)","enrollment":95},{"nctId":"NCT05405972","phase":"NA","title":"A Behavioral Intervention With Foster Families","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2022-05-15","conditions":"Family Relationship, Sibling Relations, Behavior, Social","enrollment":95},{"nctId":"NCT02996825","phase":"PHASE1","title":"Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2017-03-22","conditions":"Recurrent Breast Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma","enrollment":44},{"nctId":"NCT06338904","phase":"NA","title":"Brief Problem-solving Intervention in Different Formats for the Prevention of Suicide in Adults Over 50","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Santiago de Compostela","startDate":"2023-09-01","conditions":"Suicide","enrollment":212},{"nctId":"NCT02889809","phase":"PHASE4","title":"Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-07-10","conditions":"Asthma","enrollment":477},{"nctId":"NCT05514912","phase":"PHASE2","title":"Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2024-03-01","conditions":"Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic Cholangiocarcinoma AJCC v8","enrollment":""},{"nctId":"NCT06174051","phase":"NA","title":"Flashforward EMDR Treatment for Patients With an ICD","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2024-02","conditions":"Anxiety and Fear","enrollment":33},{"nctId":"NCT05127304","phase":"","title":"A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-02-26","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":11316},{"nctId":"NCT00942331","phase":"PHASE3","title":"Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-07-15","conditions":"Advanced Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma, Metastatic Prostate Carcinoma","enrollment":506},{"nctId":"NCT05395052","phase":"PHASE1","title":"FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors","status":"TERMINATED","sponsor":"Fate Therapeutics","startDate":"2022-05-31","conditions":"Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer","enrollment":5},{"nctId":"NCT04398368","phase":"PHASE2","title":"Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2020-06-05","conditions":"Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8","enrollment":25},{"nctId":"NCT05097014","phase":"PHASE4","title":"CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-10-28","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":106},{"nctId":"NCT04077970","phase":"PHASE3","title":"Intrauterine Flushing With Follicular Fluid Plus Granulosa Cells","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2018-11-01","conditions":"Follicular Fluid, Granulosa Cell, Embryo Implantation","enrollment":140},{"nctId":"NCT05733000","phase":"PHASE2","title":"CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2023-03-08","conditions":"Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma","enrollment":94},{"nctId":"NCT05738642","phase":"NA","title":"Evaluation of the Efficacy of Early Bunching of a FF-PCC in Patients With Severe Traumatic Hemorrhage","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-01","conditions":"Trauma","enrollment":380},{"nctId":"NCT05681416","phase":"NA","title":"Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer","status":"NOT_YET_RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2023-02-01","conditions":"Prostate Cancer, Familial Prostate Cancer","enrollment":300},{"nctId":"NCT04822506","phase":"NA","title":"PEA Promote Gastrointestinal Function Recovered After Colorectal Cancer Operation","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2021-07-31","conditions":"Colorectal Cancer","enrollment":30},{"nctId":"NCT03795350","phase":"PHASE1","title":"Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients","status":"TERMINATED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2019-01-14","conditions":"Chronic Obstructive Pulmonary Disease, Asthma","enrollment":19},{"nctId":"NCT04101292","phase":"NA","title":"Endoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours (Elios-Color-on-Specimen)","status":"WITHDRAWN","sponsor":"IHU Strasbourg","startDate":"2021-04","conditions":"Colorectal Cancer","enrollment":""},{"nctId":"NCT04841551","phase":"PHASE4","title":"Kybella for the Treatment of Flank Fat (FF)","status":"COMPLETED","sponsor":"Beer, Kenneth R., M.D., PA","startDate":"2021-07-22","conditions":"Adiposity","enrollment":10},{"nctId":"NCT04876677","phase":"PHASE3","title":"Functional Respiratory Imaging Study","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-05-25","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":25},{"nctId":"NCT01595061","phase":"PHASE2","title":"Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva","status":"UNKNOWN","sponsor":"Gynecologic Oncology Group","startDate":"2012-07-02","conditions":"Stage III Vulvar Cancer AJCC v7, Stage IIIA Vulvar Cancer AJCC v7, Stage IIIB Vulvar Cancer AJCC v7","enrollment":57},{"nctId":"NCT03791853","phase":"","title":"Light-CT in the Diagnosis of Breast Tumor and Lymph Node","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2018-04-01","conditions":"Breast Neoplasms","enrollment":150},{"nctId":"NCT02000609","phase":"PHASE2","title":"A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of \"Nexthaler\" Dry Powder Inhaler in COPD Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2013-12","conditions":"COPD","enrollment":49},{"nctId":"NCT00929851","phase":"PHASE3","title":"BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2009-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":1199},{"nctId":"NCT02287272","phase":"PHASE1","title":"Drug-drug Interaction Study of CHF5993 With Cimetidine","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-05","conditions":"COPD","enrollment":25},{"nctId":"NCT02467452","phase":"PHASE3","title":"Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2015-05","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1479},{"nctId":"NCT01917331","phase":"PHASE3","title":"Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-03","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1368},{"nctId":"NCT01911364","phase":"PHASE3","title":"Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2014-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":3686},{"nctId":"NCT02579850","phase":"PHASE3","title":"2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2015-05-29","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1532},{"nctId":"NCT01476813","phase":"PHASE2","title":"Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-03","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":281}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15818,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"FF","genericName":"FF","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FF is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and improves bronchodilation in respiratory disease. Used for Chronic obstructive pulmonary disease (COPD) maintenance treatment, Asthma maintenance treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}